PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 44 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $591,000 | +11720.0% | 705,907 | +6197.7% | 0.02% | – |
| Q4 2016 | $5,000 | -28.6% | 11,209 | -7.9% | 0.00% | – |
| Q3 2016 | $7,000 | 0.0% | 12,164 | +17.6% | 0.00% | – |
| Q2 2016 | $7,000 | -72.0% | 10,340 | -25.0% | 0.00% | -100.0% |
| Q1 2015 | $25,000 | -24.2% | 13,781 | -22.0% | 0.00% | 0.0% |
| Q4 2014 | $33,000 | -31.2% | 17,674 | +33.1% | 0.00% | 0.0% |
| Q2 2014 | $48,000 | – | 13,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,825,000 | $1,206,000 | 0.39% |
| Zhang Financial LLC | 45,000 | $33,000 | 0.02% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 472,553 | $313,000 | 0.01% |
| MEITAV INVESTMENT HOUSE LTD | 127,062 | $85,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 324,479 | $215,000,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 302,588 | $200,000 | 0.00% |
| Renaissance Technologies | 1,993,500 | $1,318,000 | 0.00% |
| WEDBUSH SECURITIES INC | 15,000 | $10,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 57,127 | $38,000 | 0.00% |
| Psagot Value Holdings Ltd. | 29,193 | $20,000 | 0.00% |